InsiderTrades

Form 4 for SGHT Sight Sciences, Inc.

Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-19 · accession 0000899243-21-028880 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-07-19 2021-07-19 SGHT Offer Andrew Dir C - Cnv Deriv — +3,162 3,162 New —
DI 2021-07-19 2021-07-19 SGHT Offer Andrew Dir C - Cnv Deriv — +2.23M 2.36M +1,721% —
D 2021-07-19 2021-07-19 SGHT Offer Andrew Dir C - Cnv Deriv — -1,581 0 -100% —
DMI 2021-07-19 2021-07-19 SGHT Offer Andrew Dir C - Cnv Deriv — -1.11M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-07-19 C A 3,162 — 3,162 D See footnote — — (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.
2 Common Common Stock 2021-07-19 C A 2,225,752 — 2,355,062 I — — (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.
3 Derivative Series C Preferred Stock 2021-07-19 C D 1,581 — 0 D See footnote — · — to — 3,162 Common Stock (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.
4 Derivative Series A Redeemable Convertible Preferred Stock 2021-07-19 C D 1,086,956 — 0 I See footnote — · — to — 2,173,912 Common Stock (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering. (F2) These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.
5 Derivative Series B Redeemable Convertible Preferred Stock 2021-07-19 C D 25,920 — 0 I — · — to — 51,840 Common Stock (F1) The preferred stock has no expiration date and automatically converted into two shares of common stock upon the closing of the Issuer's initial public offering.